These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22187944)

  • 21. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients.
    Wu W; Li J; Chen F; Zhu H; Peng G; Chen Z
    J Gastroenterol Hepatol; 2010 Apr; 25(4):750-7. PubMed ID: 20492330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
    Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
    J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B.
    Lin CY; Tsai MC; Huang CT; Hsu CW; Tseng SC; Tsai IF; Chen YC; Yeh CT; Sheen IS; Chien RN
    J Viral Hepat; 2007 Jul; 14(7):503-11. PubMed ID: 17576392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
    Agrewala JN; Suvas S; Verma RK; Mishra GC
    J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C.
    Mochizuki K; Hayashi N; Katayama K; Hiramatsu N; Kanto T; Mita E; Tatsumi T; Kuzushita N; Kasahara A; Fusamoto H; Yokochi T; Kamada T
    Hepatology; 1997 Mar; 25(3):713-8. PubMed ID: 9049224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice.
    Yu MC; Chen CH; Liang X; Wang L; Gandhi CR; Fung JJ; Lu L; Qian S
    Hepatology; 2004 Dec; 40(6):1312-21. PubMed ID: 15565659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma].
    Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
    Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
    Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.
    Jiang W
    Vaccine; 2012 Jan; 30(4):758-66. PubMed ID: 22133510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
    Zhang Z; Zhang JY; Wang LF; Wang FS
    J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B7-DC-silenced dendritic cells induce stronger anti-HBV immunity in transgenic mice.
    Fan Y; Jiang WZ; Wen JJ; Hao WL; Du JN; Liu X; Qian M
    Arch Virol; 2009; 154(11):1813-21. PubMed ID: 19838621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
    Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
    Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients.
    Kountouras J; Boura P; Tsapas G
    Hepatogastroenterology; 1998; 45(24):2295-302. PubMed ID: 9951912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure.
    Shi F; Zhang JY; Zeng Z; Tien P; Wang FS
    Biochem Biophys Res Commun; 2010 Nov; 402(1):30-6. PubMed ID: 20883666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.